相关实验视频
Updated: Sep 14, 2025

06:09
An In Ovo Model for Testing Insulin-mimetic Compounds
Published on: April 23, 2018
10.8K
通过因果学习和虚拟患者模拟2型糖尿病中的真实世界GLP-1疗效
Calum Robert MacLellan1, Hristo Petkov2, Conor McKeag3
1Department of Biomedical Engineering, University of Strathclyde, Glasgow, United Kingdom.
PLOS digital health
|July 21, 2025
概括
生成型人工智能 (AI) 使虚拟临床试验能够模拟2型糖尿病 (T2DM) 治疗的随机对照试验 (RCT). 这种人工智能方法可以准确预测治疗效果,从而有可能将RCT的通用性扩展到现实世界的人口中.
科学领域:
- 生物医学信息学 生物医学信息学
- 人工智能在医学中的应用
- 临床试验方法论 临床试验方法论
背景情况:
- 随机对照试验 (RCT) 是治疗效果的黄金标准,但其人群有限.
- 将RCT的发现推断到各种现实世界的人口仍然是一个挑战.
- 生成型人工智能提供了一种新的方法来模拟临床试验并扩大概括性.
研究的目的:
- 为虚拟临床试验引入和验证一种生成人工智能 (AI) 驱动的仿真方法.
- 通过模拟RCT过程并潜在地推断到更广泛的人群来推断治疗效果大小.
- 为了比较AI仿真对葡萄糖类-1 (GLP-1) 激素在2型糖尿病 (T2DM) 中有效性的预测,与已建立的试验数据.
主要方法:
- 开发了一种生成性AI和因果学习方法,用于在真实世界的证据数据上训练模拟模型.
- 在GLP-1,基础胰岛素和安慰剂臂中利用了5,476名T2DM患者的治疗前后结果.
- 通过采样患者和预测结果进行虚拟试验,使用差异差异 (DiD) 进行对对比.
主要成果:
- 在虚拟试验中,人工智能仿真成功地预测了GLP-1激动剂的显著HbA1c降低,与基础胰岛素和安慰剂相比.
- 针对GLP-1与基础胰岛素 (-1.21 mmol/mol) 和GLP-1与安慰剂 (-2.58 mmol/mol) 的虚拟试验结果与LEAD-5试验结果一致.
- 人工智能模型证明了其能够模拟现实世界临床试验 (LEAD-5) 的关键测量结果.
结论:
- 因果AI驱动的虚拟临床试验可以有效地模拟已建立的RCT来确定T2DM治疗疗效.
- 这种人工智能方法显示了探索反事实和评估RCT结果的概括性的潜力.
- 该方法支持临床决策和政策建议,通过将RCT发现与现实世界的应用联系起来.
更多相关视频
相关概念视频
Glucagon-like Receptor Agonists
421
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
421
EPS and iPS Cells in Disease Research
2.9K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.9K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Purposive Learning
207
E. C. Tolman emphasized the purposiveness of behavior — the idea that much of our behavior is goal-directed. For instance, employees who aim for a promotion work diligently to meet their targets. Tolman argued that when classical conditioning and operant conditioning occur, the organism acquires certain expectations. In classical conditioning, a child might fear a dog because they expect it to bite. In operant conditioning, a person might consistently work overtime because they expect a...
207
Diabetes: Management and Pharmacotherapy
399
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
399

